Assessment of self-injection experience in patients with rheumatoid arthritis: Psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ)

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Keininger, Dorothy ^a   Coteur, Geoffroy ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CERTOLIZUMAB PEGOL; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PSYCHOMETRY; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SELF ESTEEM; SELF INJECTION; SELF INJECTION ASSESSMENT QUESTIONNAIRE; DRUG SELF ADMINISTRATION; FACTORIAL ANALYSIS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REPRODUCIBILITY; STANDARD; SUBCUTANEOUS DRUG ADMINISTRATION; VALIDATION STUDY;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF ADMINISTRATION;

EID: 78651326041     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-2     Document Type: Article

References (37)

1. Sacks JJ, Helmick CG, Langmaid G. Deaths from arthritis and other rheumatic conditions, United States, 1979-1998. J Rheumatol 2004, 31:1823-1828.
2. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001, 358:903-911. 10.1016/S0140-6736(01)06075-5, 11567728.
3. Mili F, Helmick CG, Moriarty DG. Health related quality of life among adults reporting arthritis: analysis of data from the Behavioral Risk Factor Surveillance System, US, 1996-99. J Rheumatol 2003, 30:160-166.
4. Strand V, Singh JA. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care 2007, 13(Suppl 9):S237-251.
5. Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med 2008, 148:124-134.
6. Schwartzman S, Fleischmann R, Morgan GJ. Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?. Arthritis Res Ther 2004, 6(Suppl 2):S3-S11. 10.1186/ar1013, 2833457, 15228615.
7. Kivitz A, Cohen S, Dowd JE, Edwards W, Thakker S, Wellborne FR, Renz CL, Segurado OG. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial. Clin Ther 2006, 28:1619-1629. 10.1016/j.clinthera.2006.10.006, 17157117.
8. Chilton F, Collett RA. Treatment choices, preferences and decision-making by patients with rheumatoid arthritis. Musculoskeletal Care 2008, 6:1-14. 10.1002/msc.110, 17726671.
9. Mohr DC, Cox D, Boudewyn A. Self-Injection Anxiety Counseling (SIAC) manual for counselors. , http://www.nationalmssociety.org/for-professionals/healthcare-professionals/resources-for-clinicians/self-injection-anxiety-counseling-siac-/index.aspx
10. Hamm R, Patel B, Whittlestone T, Persad R. Patient self-injection: a new approach to administering luteinizing hormone-releasing hormone analogues. BJU Int 2000, 86:840-842. 10.1046/j.1464-410x.2000.00910.x, 11069411.
11. Nir Y, Paz A, Sabo E, Potasman I. Fear of injections in young adults: prevalence and associations. Am J Trop Med Hyg 2003, 68:341-344.
12. Willershausen B, Azrak A, Wilms S. Fear of dental treatment and its possible effects on oral health. Eur J Med Res 1999, 4:72-77.
13. Smolen JS, Landewe RB, Mease PJ, Brzezicki J, Mason D, Luijtens K, van Vollenhoven RF, Kavanaugh A, Schiff MH, Burmester GR, et al. Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. Ann Rheum Dis 2009, 68:797-804. 10.1136/ard.2008.101659, 2674556, 19015207.
14. Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS. Patient-reported outcomes: instrument development and selection issues. Value Health 2007, 10(Suppl 2):S86-93. 10.1111/j.1524-4733.2007.00271.x, 17995478.
15. Food and Drug Administration Patient-reported outcome measures: use in medical product development to support labeling claims. Food and Drug Administration., http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdf
16. Acquadro C, Conway K, Giroudet C, Mear I. Linguistic validation manual for patient-reported outcomes instruments. 2004, Lyon: Mapi Research Institute.
17. Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD. What is sufficient evidence for the reliability and validity of patient-reported outcome measures?. Value Health 2007, 10(Suppl 2):S94-S105. 10.1111/j.1524-4733.2007.00272.x, 17995479.
18. Fang J. Medical statistics and computer experiments. 2005, Singapore: Stallion Press.
19. Bentler PM, Bonett DG. Significance tests and goodness-of-fit in the analysis of 22 covariance structures. Psychol Bull 1980, 88:588-606.
20. Brown TA. Confirmatory factor analysis for applied research. 2006, New York: Guilford Press, 1.
21. Jöreskog KG, Sörbom D. LISREL VI; Analysis of linear structural relationships by maximum likelihood, instrumental variables, and least squares. 1985, Uppsala: University of Uppsala.
22. Fayers PM, Machin D. Quality of life: assessment, analysis and interpretation. 2000, Chichester: John Wiley & Sons, Ltd.
23. Ouwerkerk JW, van Pelt PA, Takken T, Helders PJ, Net J. Evaluating score distributions in the revised Dutch version of the Childhood Health Assessment Questionnaire. Pediatr Rheumatol Online J 2008, 6:14. 10.1186/1546-0096-6-14, 2546387, 18786245.
24. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16:297-334.
25. Nunnally JC, Bernstein I. Psychometric theory. 1993, New York: McGraw-Hill, 3.
26. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment 1998, 2:1-74.
27. Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc 2007, 82:591-605. 10.1111/j.1469-185X.2007.00027.x, 17944619.
28. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003, 30:167-178.
29. Keystone E, Heijde D, Mason D, Landewe R, Vollenhoven RV, Combe B, Emery P, Strand V, Mease P, Desai C, et al. Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 2008, 58:3319-3329. 10.1002/art.23964, 18975346.
30. Fleischmann R, Vencovsky J, van Vollenhoven R, Borenstein D, Box J, Coteur G, Goel N, Brezinschek HP, Innes A, Strand V. Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study. Ann Rheum Dis 2009, 68:805-811. 10.1136/ard.2008.099291, 2674555, 19015206.
31. Szeinbach SL, Barnes JH, Summers KH, Lenox SM. Development of an instrument to assess expectations of and preference for an insulin injection pen compared with the vial and syringe. Clin Ther 2004, 26:590-597. 10.1016/S0149-2918(04)90061-6, 15189756.
32. Green J, Kleinman L, Ciesla G, Huang J, Wintfeld N, Revicki D. Subcutaneous injection survey: psychometric evaluation of a treatment satisfaction instrument associated with a novel HIV medication. HIV Clin Trials 2002, 3:387-395. 10.1310/TT4M-WKFF-JTJ7-VQU6, 12407488.
33. Chevat C, Viala-Danten M, Dias-Barbosa C, Nguyen VH. Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI) questionnaire. Health Qual Life Outcomes 2009, 7:21. 10.1186/1477-7525-7-21, 2660294, 19261173.
34. Mollema ED, Snoek FJ, Pouwer F, Heine RJ, van der Ploeg HM. Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation. Diabetes Care 2000, 23:765-769. 10.2337/diacare.23.6.765, 10840993.
35. Snoek FJ, Mollema ED, Heine RJ, Bouter LM, van der Ploeg HM. Development and validation of the Diabetes Fear of Injecting and Self-Testing Questionnaire (D-FISQ): first findings. Diabet Med 1997, 14:871-876. 10.1002/(SICI)1096-9136(199710)14:10<871::AID-DIA457>3.0.CO;2-Y, 9371481.
36. Guadagnoli E, Velicer WF. Relation of sample size to the stability of component patterns. Psychol Bull 1988, 103:265-275. 10.1037/0033-2909.103.2.265, 3363047.
37. Locker D, Jokovic A, Allison P. Direction of wording and responses to items in oral health-related quality of life questionnaires for children and their parents. Community Dent Oral Epidemiol 2007, 35:255-262. 10.1111/j.1600-0528.2007.00320.x, 17615012.